TargetTyrosine-protein kinase FRK(Homo sapiens (Human))
University Court Of The University Of Edinburgh
US Patent
University Court Of The University Of Edinburgh
US Patent
Affinity DataIC50: <10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase FRK(Homo sapiens (Human))
University Court Of The University Of Edinburgh
US Patent
University Court Of The University Of Edinburgh
US Patent
Affinity DataIC50: <10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase FRK(Homo sapiens (Human))
University Court Of The University Of Edinburgh
US Patent
University Court Of The University Of Edinburgh
US Patent
Affinity DataKd: 0.310nMAssay Description:Binding constant for FRK kinase domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase FRK(Homo sapiens (Human))
University Court Of The University Of Edinburgh
US Patent
University Court Of The University Of Edinburgh
US Patent
Affinity DataKd: 0.310nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase FRK(Homo sapiens (Human))
University Court Of The University Of Edinburgh
US Patent
University Court Of The University Of Edinburgh
US Patent
Affinity DataKd: 0.310nMAssay Description:Binding constant for FRK kinase domainMore data for this Ligand-Target Pair